Allergies and asthma are among the most common diseases in industrialized countries. Although environmental factors play an important role in allergic diseases, estimates of the heritability of allergy, which range between 25% and 80%, suggest a significant genetic contribution. 1 Genome-wide association studies (GWASs) have identified a number of loci associated with allergic diseases (ie, asthma, atopic dermatitis, and rhinitis), 2, 3 but these loci only explain a small part of the genetic risk. Part of the difficulty encountered in identifying the genetic factors involved in these allergic diseases is due to the heterogeneity of these diseases and the uncertainty of diagnosis. However, this problem can be alleviated by the study of an endotype underlying allergic diseases, such as allergic sensitization or atopy.
Atopy is characterized by production of allergen-specific IgE against environmental allergens. Estimates of heritability of atopy range from 40% to 85%. 4, 5 Many candidate genetic studies of atopy have been conducted but have often led to inconsistent results. 6 Although the first GWAS of allergic sensitization reported only a few loci, 7-10 2 recent large-scale meta-analyses of allergic sensitization 11 and self-reported allergy 12 increased the number of associated loci to 10 and 16, respectively. However, other loci can influence atopy because it is well known that a GWAS alone cannot reveal the whole genetic landscape underlying complex phenotypes.
Heterogeneity across studies, which can be caused by variability in the genetic background of the populations, environmental exposures, or study design, might be a limitation of meta-analyses of GWASs for identifying new loci associated with a trait. Notably, the importance of data sampling was highlighted recently by a positional cloning study of eczema in which association with ANO3/MUC15 genetic variants was only found in family samples ascertained through asthmatic patients but not in families ascertained through patients with eczema or in a case-control study of eczema. 13 Another limitation of GWASs is that they typically focus on analysis of individual single nucleotide polymorphisms (SNPs) and are underpowered to detect genetic factors, which have a small marginal effect but rather interact with each other. Gene-gene interaction analysis (or epistasis analysis) has the ability to reveal novel genes involved in complex traits but raises an enormous multiple-testing problem when performed at the genome-wide level. Statistical and biological filtering pipelines can be used to limit the search for SNP-SNP interactions.
14 Following the ''guilt-by-association'' assumption, which states that connected genes participate usually in the same or related cellular functions, 15 search for interactions can be restricted to genes pointed out by a preliminary GWAS (eg, interactions of genes harboring significant association signals with genes harboring suggestive associations) and showing relationships based on prior knowledge. One knowledge-based approach that can be particularly useful to prioritize genes for epistasis analysis is text mining of the literature because it can highlight relationships between genes 16 according to their co-occurrence with the same words in scientific articles.
The objective of this study was to identify novel genetic factors influencing atopy by combining a GWAS and epistasis analysis driven by statistical and knowledge-based evidence in 3 family samples ascertained through asthmatic patients: the French Epidemiological Study on the Genetics and Environment of Asthma (EGEA; 1660 subjects), the French-Canadian Saguenay-Lac-SaintJean (SLSJ) study (1138 subjects), and the Medical Research Council (MRC) UK study (446 subjects). Our overall analysis strategy included 3 main steps: (1) a genome-wide single-SNP association analysis, (2) the selection of related gene pairs based on statistical filtering from GWAS results and text-mining filtering using the Gene Relationships Across Implicated Loci (GRAIL) approach, 17 and (3) an SNP-SNP interaction analysis for the selected gene pairs.
METHODS

Study data sets and definition of atopy
The EGEA study combines a case-control and family-based study of asthma. The whole study population includes 388 families ascertained through at least 1 asthmatic proband recruited in chest clinics (1705 probands and first-degree relatives) plus 415 population-based control subjects (total of 2120 subjects). All subjects were born in France and were of European ancestry. The protocol of this study has been described elsewhere. [18] [19] [20] Atopy was assessed by using skin prick tests (SPT) performed in 1978 subjects. A positive SPT response was defined as a wheal diameter of 3 mm or greater to at least 1 of 11 aeroallergens belonging to 3 groups (indoor allergens, outdoor allergens, and molds). After quality control (QC) of genotypic data, 925 atopic and 735 nonatopic subjects were included in the analysis.
The Saguenay-Lac-Saint-Jean and Quebec City Familial Asthma Collection (SLSJ) consists of a French-Canadian founder population panel of 253 multigenerational families from the Saguenay-Lac-Saint-Jean region ascertained through 2 asthmatic probands. 21 This study has been described elsewhere. 21 Skin tests were done in 1195 SLSJ subjects, and atopy was defined similarly as in EGEA. After QC of genotypic data, the analysis data set included 641 atopic and 497 nonatopic subjects.
The Medical Research Council-funded collection of nuclear families with Asthma (MRCA) UK study includes 207 nuclear families recruited through at least 1 proband with childhood-onset asthma. The study protocol has been described elsewhere. 22 Atopy was defined similarly as in EGEA. To increase the number of unaffected subjects (control subjects), we included subjects from the Medical Research Council-funded collection of nuclear families with Eczema (MRCE) UK data set that were recruited through probands with eczema. Only subjects without asthma, without eczema, and with low IgE levels were used as control subjects in this study. We checked that age and sex distributions were similar in MRCA and MRCE samples. After QC of genotypic data, the analysis sample included 106 atopic and 340 nonatopic subjects. The whole UK sample will be subsequently designated as the MRC sample.
Protocols of EGEA, the SLSJ study, and MRC studies have been approved by local ethical committees. All adult participants and children's legal guardians provided written informed consent.
Genotyping
Both the EGEA and SLSJ data sets were genotyped with the Illumina 610-Quad Array (Illumina, San Diego, Calif) as part as of the GABRIEL asthma consortium GWAS. 23 Stringent quality criteria were applied to select both patients and SNPs, and these have been detailed previously. 23, 24 After QC, there was a final set of 501,167 autosomal SNPs for analysis. Offspring in MRCA families and MRCE control subjects were genotyped by using the Illumina Sentrix HumanHap300 BeadChip (307,981 autosomal SNPs) as part of the first asthma GWAS. 22, 23 QC for MRC samples has been detailed elsewhere. 22, 25 SNP imputation was performed by using MACH v1.00 software 26 and HapMap2 release 21 CEU haplotypes as a reference panel to make the number of SNPs in MRC sample as large as the number in EGEA and SLSJ samples. Imputed SNPs were kept for analysis if their imputation quality score (rsq) 27 was 0.5 or greater and minor allele frequency was 5% or greater.
Descriptive statistics and analysis strategy
Descriptive statistics of atopy together with sex, age, and asthma status were assessed in each data set by using Stata software (version 14.1; distributed by Stata, College Station, Tex). The workflow of our 3-step analysis strategy is summarized in Fig 1 and presented in the following paragraphs.
for SNP effect by using Stata software (version 14.1). This model was adjusted for significant effects of age and sex and 2 principal components to account for population structure. We took into account familial dependencies using the cluster and robust options of the logit function in Stata software. Test of SNP effect was based on a Wald test. In a second stage the SNPs reaching a P value of 10 24 or less in EGEA were followed up in the SLSJ and MRC studies. The association analysis in the SLSJ and MRC studies used the same model as in EGEA. Results of stage 2 data sets and then of the 3 data sets were combined by using a fixed-effects meta-analysis. SNPs were declared to be significantly associated with atopy if the meta-analysis P value (P meta ) of 3 data sets reached the genome-wide significance level of 1.5 3 10 27 . This threshold was obtained by dividing the type I error of 5% by the effective number of independent SNPs in the Illumina 610-Quad array.
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Selection of gene pairs using both statistical and text-mining filters Statistical filtering consisted of selecting 2 sets of genes using the GWAS results: genes showing significant association with atopy (set 1) and genes showing suggestive association with atopy (set 2). Set 1 included all genes at a distance of 50 kb or less from SNPs reaching the genome-wide significance level in the GWAS meta-analysis. Set 2 included all genes that were at most 50 kb apart from SNPs with a P value of 10 24 or less in the stage 1 EGEA data set and were not part of set 1. To assign SNPs to genes, we used the National Center for Biotechnology Information's dbSNP Build 137 and human Genome Build 37.3. We further filtered gene pairs (formed by crossing set 1 genes with set 2 genes) through GRAIL 17 text mining of PubMed abstracts (available in October 2014). For each gene, GRAIL builds a vector of words in which the elements of this vector are weights that take values between 0 and 1 depending on how often a word is found with a gene in an abstract. Then GRAIL computes pairwise similarity between genes from gene/word vectors and ranks the similarities between each gene from set 1 and all genes of the genome. The P GRAIL value of a gene from set 2 with a gene from set 1 is equal to the proportion of all genes that have similarity with the set 1 gene greater than the similarity between set 2 and set 1 genes (ie, rank divided by total number of genes across the genome). We used the threshold of a P GRAIL value of .10 or less, as recommended, 17 to select related gene pairs for further epistasis analysis.
SNP-SNP interaction analysis for selected gene pairs
As for the single-SNP association analysis, we performed a 2-stage SNP-SNP interaction analysis. At stage 1, we analyzed all SNP-SNP interactions for the GRAIL-selected gene pairs in the EGEA data set. For each gene, we considered all SNPs lying within gene boundaries. Pairwise SNP-SNP interactions were evaluated by using logistic regression, assuming an additive model for SNP main effects and interaction and adjusting for the same covariates (age, sex, and principal components) as in the GWAS by using Stata software (version 14.1). We used the same coding scheme as usually proposed for SNP-SNP interaction modeling. 29 We modeled the additive effect of an SNP by coding the genotypes of homozygotes for the minor allele, heterozygotes, and homozygotes for the major allele as 1, 0, and 21; the interaction term between 2 SNPs was obtained by means of multiplication of these genotypic values for the 2 SNPs. The test of interaction was based on a likelihood ratio test that follows a x 2 distribution with 1 df. We discarded all SNP pairs for which 1 or more of the 9 genotype combinations appeared in fewer than 5 subjects (cases or control subjects). In a second stage all SNP pairs showing suggestive evidence for interaction in EGEA (P int < _ 5 3 10 23 ) were followed up in the SLSJ and MRC studies. The results of the stage 2 data sets and then of the 3 data sets were meta-analyzed by using a fixed-effects model. To correct for multiple testing, for each gene pair investigated, we computed the effective number of independent interaction tests from the eigenvalues of the correlation matrix of products of SNP variables by using an J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 5 extension of the method of Li and Ji. 30 The corrected threshold to declare an interaction statistically significant was equal to the 5% type I error divided by the sum of the effective number of independent interaction tests over all gene pairs tested.
Stratified analyses according to asthma status
Because family samples were ascertained through asthmatic probands, we investigated whether SNP associations and SNP-SNP interactions detected with atopy might be related to the presence of asthma. Single-SNP and SNP-SNP interaction analyses were repeated in the 2 groups of asthmatic and nonasthmatic subjects separately. These analyses were performed for SNPs that showed significant results in meta-analyses of the 3 data sets. Homogeneity of the odds ratios (ORs) between the 2 groups was tested by using the Cochran Q statistic. 31 
RESULTS
Descriptive statistics
A total of 1660 EGEA, 1138 SLSJ study, and 446 MRC study subjects were included in this study. The proportion of atopic subjects was similar in EGEA and SLSJ studies (55.7% and 56.3%, respectively) but was lower in the MRC study (23.8%, P < _ 10 23 ). In each study there was a higher proportion of male subjects among atopic than in nonatopic subjects, and atopic subjects were younger than nonatopic subjects (see Table E1 in this article's Online Repository at www.jacionline.org). As expected, the proportion of asthmatic patients was higher in atopic than in nonatopic subjects in all data sets (see Table E1 ). In EGEA 78.0% (75.0% and 78.3% in the SLSJ and MRC studies, respectively) of atopic subjects had positive SPT responses to indoor allergens, 55.5% (77.5% and 52.8% in the SLSJ and MRC studies, respectively) to outdoor allergens, and 34.8% (14.8% and 12.3% in the SLSJ and MRC studies, respectively) to molds.
Genome-wide single-SNP analysis
In the stage 1 EGEA data set, no SNP reached the genome-wide significance level of 1.5 3 10
27 (see quantile-quantile and Manhattan plots in Figs E1 and E2 in this article's Online Repository at www.jacionline.org). However, 73 SNPs in 47 loci showed associations with atopy exceeding the screening threshold of a P value of 10 24 or less. These SNPs were followed up in the stage 2 SLSJ and MRC data sets and meta-analyzed (see Table E2 in this article's Online Repository at www.jacionline. org). The SNP rs4916831 within the adhesion G protein-coupled receptor V1 (ADGRV1) gene at 5q14 reached the genome-wide significance level (P meta 5 6.8 3 10
29 ) in the overall meta-analysis of the 3 data sets (Table I) . Four other SNPs at that locus in moderate linkage disequilibrium (LD) with rs4916831 (r 2 range, 0.51-0.79) showed a suggestive association (4.3 3 10 27 < _ P meta < _ 3.8 3 10 26 , Table I ).
Selection of gene pairs by using both statistical and text-mining filters
Gene set 1 included ADGRV1, the only gene significantly associated with atopy. There were 30 genes that were fewer than 50 kb apart from the 65 SNPs at 46 loci with a P value of 10 24 or less in EGEA (after exclusion of ADGRV1 SNPs), and these formed gene set 2 (see Table E3 in this article's Online Repository at www.jacionline.org). When GRAIL was applied to 30 gene pairs (date accessed: April 24, 2015) formed by each of these 30 genes with ADGRV1, 3 genes were related to ADGRV1 at a P GRAIL value of less than .10: dynein axonemal heavy chain 5 (DNAH5) on 5p15 (P GRAIL 5 .084), CHD7 on 8q12 (P GRAIL 5 3.2 3 10
23
), and ATP8B1 on 18q21 (P GRAIL 5 .016).
SNP-SNP interaction analysis for selected gene pairs
In the stage 1 EGEA data set, the 3 GRAIL-selected gene pairs (ADGRV1/DNAH5, ADGRV1/CHD7, and ADGRV1/ATP8B1) were each examined for SNP-SNP interactions, making a total of 5324 SNP pairs. There were 37 SNP pairs that reached a P int value of 5 3 10 23 or less in EGEA, and these were followed up in the SLSJ and MRC studies at stage 2. Two of these SNP pairs, which are related to the ADGRV1-DNAH5 gene pair, met the multiple-testing corrected threshold, which is estimated to be 7.3 3 10
25 (see Table E4 in this article's Online Repository at www.jacionline.org), in the meta-analysis of the 3 data sets (Table II) . The 2 significant interactions involved the same SNP, rs17554723, within ADGRV1 and 2 SNPs within DNAH5, rs2134256 (P meta-int 5 3.6 3 10
25
) and rs1354187 (P meta-int 5 6.1 3 10 25 ), that are in moderate LD (r 2 5 0.50, D9 5 0.95). However, further conditional regression analysis in each of the strata defined by genotypes at ADGRV1 rs17554723 showed that DNAH5 rs1354187 was no longer significantly ); and **P value associated with the Cochran Q test of homogeneity across the 3 data sets.
associated with atopy (P > _ .15) when conditioning on DNAH5 rs2134256. The most significant SNP pair shows a pattern of interaction in which the ORs for atopy associated with the TT (or CC) genotype at DNAH5 rs2134256 are in opposite directions according to genotype AA (or GG) at ADGRV1 rs17554723 (Fig 2) . This pattern was consistent in all 3 data sets (Fig 2) .
Stratified analyses according to asthma status
Association analyses of atopy with the genome-wide significant ADGRV1 rs4916831 SNP in asthmatic and nonasthmatic subjects did not show any relationship with the presence of asthma in the stage 1 and 2 data sets and meta-analysis of the 3 data sets (P Cochran for test of homogeneity between the 2 groups > _ .82; see Table E5 , top, in this article's Online Repository at www.jacionline.org). In the meta-analysis the evidence for association was even stronger, although not significantly so in nonasthmatic subjects (P 5 7.8 3 10
26
) than in asthmatic patients (P 5 1.4 3 10 24 ). Similarly, interaction analyses for ADGRV1 and DNAH5 SNPs did not show any relationship with asthma (P Cochran > _ .30; see Table E5 , bottom). The evidence for interaction was only significant in nonasthmatic subjects (see Table E6 , in this article's Online Repository at www. jacionline.org); this can be explained, at least in part, by the larger sample size of nonasthmatic (n 5 1849) than asthmatic (n 5 1354) subjects.
Functional annotations of SNPs showing significant results
All SNPs that show significant association (or interaction) with atopy are intronic. The 2 ADGRV1 SNPs, rs4916831 and rs17554723, on 5q14, which were detected through GWAS and interaction analysis, are 120 kb apart in introns 83 (rs4916831) and 70 (rs17554723) and are in low LD (r 2 5 0.20, D9 5 0.75). The 2 DNAH5 SNPs (rs2134256 and rs1354187) at 5p15.2 are located in introns 58 and 60 (8 kb apart), but only rs2134256 accounts for the interaction signal (see above). By interrogating the Genotype-Tissue Expression database, 32 rs4916831 was found to be associated with ADGRV1 expression in esophageal mucosa (P 5 7.5 3 10
27
). 32 We also investigated whether the ADGRV1 and DNAH5 SNPs (as well as their proxies, r 2 > _ 0.80) map to functionally important regulatory regions using HaploRegV4. 33 As shown in Table E6 , these SNPs and/or proxies map to binding sites of various transcription factors. In addition, 4 proxies of ADGRV1 rs4916831 map to enhancer histone marks in the lung and skin, whereas a proxy of DNAH5 rs2134256 maps to promoter and enhancer marks in hematopoietic stem cells.
DISCUSSION
By combining genome-wide single-SNP analysis and epistasis analysis driven by statistical and knowledge-based evidence in 3 asthma-ascertained family data sets, we identified significant association of atopy at a novel 5q14 locus harboring the ADGRV1 gene and significant interaction between ADGRV1 and DNAH5 genetic variants.
Interaction between ADGRV1 and DNAH5 variants has biological relevance because these 2 genes are involved in ciliopathies and ciliary function. Ciliopathies comprise a group of disorders associated with genetic mutations encoding defective proteins, which result in either abnormal formation or function of cilia. 34 Mutations in the ADGRV1 gene cause Usher syndrome type IIC, a ciliopathy characterized by hearing loss and visual impairment, 35, 36 whereas mutations of the DNAH5 gene cause primary ciliary dyskinesia type 3, a ciliopathy that combines upper and lower tract respiratory manifestations, male infertility, and situs inversus. 37 The ADGRV1 protein (also called GPR98) is a component of the Usher protein network that functions in stereocilia of inner-ear hair cells and photoreceptor cilia. The heavy chain of axonemal dynein, as encoded by DNAH5, is part of a microtubule-associated motor protein complex responsible for cilia mobility, especially in respiratory epithelial cells, where ciliary motility is essential for mucus transport and airway clearance. 38 Although the respective function of the ADGRV1 and DNAH5 proteins was initially described in different organs, these proteins can also have related functions. Indeed, the cilium in photoreceptors is ultrastructurally very similar to the nasal ciliated epithelium, and the nasal ciliated epithelium of patients with Usher syndrome II was found to have a lower ciliary beat frequency than healthy control subjects. 39 Moreover, Usher syndrome has been reported to be associated with bronchiectasis, sinusitis, and reduced nasal mucociliary clearance. 40 In addition to the involvement of both ADGRV1 and DNAH5 proteins in ciliary functions, which supports the statistical interaction found between these 2 genes, both DNAH5 and ADGRV1 have been associated with respiratory diseases and related phenotypes. A recent GWAS reported significant Stage 2 Overall meta-analysis SLSJ study (n 5 1,138) MRC studies (n 5 446) Meta-analysis association of DNAH5 variants with total lung capacity in patients with chronic obstructive pulmonary disease 41 and suggestive association with IgE grass sensitization. 9 However, the SNP reported by that latter study was not in LD with the DNAH5 SNPs interacting with ADGRV1 SNP in this study (r 2 < 0.13). Based on an approach similar to ours, which combined genome-wide expression data in nasal epithelial cells, allele frequency variation between populations, and literature search to select candidate genes, nominal association of asthma with DNAH5 was reported, and stronger association was found with KIF3, a gene involved in transport of protein complexes within cilia and potentially in allergen clearance as DNAH5. 42 In addition, DNAH5 belongs to the same gene family as DNAH9, which showed interaction with environmental tobacco smoke exposure for bronchial hyperresponsiveness in EGEA and SLSJ families. 43 Moreover, suggestive association of ADGRV1 with asthma has been reported recently by a meta-analysis of GWASs. 44 Although most previously reported associations concern asthma or respiratory phenotypes, the interaction between ADGRV1 and DNAH5 SNPs associated with atopy in the present study appears independent of asthma, as shown by the stratified analysis on asthma. Although the mechanism by which these 2 genes influence atopy is still unknown, we can hypothesize that they are involved in dysfunction of cilia that move secreted mucus-containing trapped foreign particles up and out of the airways, which favors allergic sensitization. This is supported by recent observations of differential mRNA expression of both ADGRV1 and DNAH5 genes in sputum from house dust mite-sensitized wheezing subjects compared with nonatopic control subjects. 45 Furthermore, both DNAH5 and other genes of the same family, including DNAH9, were among the highest-ranking coexpression hubs in one of the house dust mite-induced wheezing-associated gene modules, which was strongly enriched with genes involved in the function of ciliated epithelial cells. 45 All these observations suggest cilia-related genes might constitute an important emerging pathway for atopy.
The strategy used in this study that enabled identifying novel relevant candidates for atopy combined genome-wide single-SNP analysis and gene-gene interaction analysis based on both statistical filtering of GWAS results and text-mining filtering. It is of note that our 3-step strategy was designed a priori and that SNP-SNP interaction tests were only performed for gene pairs selected through our 2 filtering processes. The genome-wide single-SNP analysis pointed to 1 gene (ADGRV1) that harbored the lead SNP rs4916831 reaching genome-wide significance and 4 other SNPs showing suggestive association. By increasing the density of SNPs through HapMap2-based imputation at that locus, an additional SNP (r 2 5 0.80 with rs4916831) reached genomewide significance, and 6 other SNPs had P values within 1 order of magnitude of the genome-wide threshold (results not shown), which strengthens our finding. Further conditional analysis in that region showed that association with atopy was accounted for only by the lead genotyped SNP. The subsequent statistical and text-mining filters used before epistasis analysis made it possible to detect gene-gene interaction by decreasing the multiple testing burden. Indeed, use of both filters reduced the number of interaction tests by 9-fold compared with use of the statistical filter only. The text-mining filter was based on GRAIL, which was shown to be successful in pointing out true disease regions that were validated. 17 Although many sources of biological information can be used to connect genes, such as coexpression gene networks or protein-protein interaction networks, the advantage of GRAIL is to provide a broader framework for revealing gene-gene relationships of any origin through literature search. However, GWASs and candidate gene studies, which are driven by researchers' expectations, can create a bias toward genes that are frequently reported in the literature. An appropriate approach would be to use the existing knowledge and to correct for potential bias, but to our knowledge, such a method does not yet exist.
In conclusion, this study shows that the proposed strategy that combines GWAS and epistasis analysis driven by statistical and knowledge-based evidence can successfully identify strong candidate genes for complex phenotypes as atopy. The interaction between DNAH5 and ADGRV1, 2 genes involved in ciliary function, is of biological relevance and provides a novel mechanism underlying atopy. Further studies, including *Chromosome represents the chromosome number at which the SNP is located; symbol of the gene where the SNP lies; àmajor allele/minor allele; §minor allele frequency; and kb for the main effect is the regression coefficient for a 1-unit increase of the effect allele in logistic regression, assuming an additive model. b for interaction is the regression coefficient for homozygotes for the minor allele at the 2 loci or homozygotes for the major allele at the 2 loci with respect to heterozygotes at either 1 or the 2 loci by using the coding scheme under an additive genetic model described in the methods section. SE represents the SE associated with the regression coefficient. {P value of the likelihood ratio test for interaction between SNPs (which follows a x 2 distribution with 1 df assuming an additive model); # P value associated with the Wald test of meta-analyzed interaction effect in the stage 2 data sets (SLSJ and MRC studies); **P value associated with the Wald test of meta-analyzed interaction effect in the 3 data sets (EGEA and SLSJ and MRC studies) (P meta-int is shown in boldface when it reached the multiple-testing corrected threshold of 7.3 3 10
25
); P value associated with the Cochran Q test of homogeneity across the 3 data sets; and ààThe 2 DNAH5 SNPs, rs1354187 and rs2134256, showing significant interaction with ADGRV1 SNP are in moderate LD (r 2 5 0.50, D9 5 0.95). ORs and 95% CIs for atopy associated with each genotype at DNAH5 rs2134256 (TT, CT, and CC) in each of the strata defined by genotypes at ADGRV1 rs17554723 (AA, AG, or GG). These ORs were calculated by using the genotype-coding scheme defined in the text and are shown for each of the 3 data sets (EGEA and the SLSJ and MRC studies) and for the combined data set.
J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 5 functional and experimental studies, are needed to confirm the current findings and identify the functional variants.
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d Use of a strategy that combines GWAS and epistasis analysis driven by statistical and knowledge-based evidence can be used to successfully identify new genes underlying complex traits. to select SNPs for follow-up in stage 2 SLSJ and MRC data sets.
J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 5 *P values for tests of distribution of each feature (sex, age, and asthma) between atopic and nonatopic subjects in each data set (x 2 test for sex and asthma; Wilcoxon-Mann-Whitney test for age).
Indoor allergens included house dust mite, cockroach, and cat in EGEA; house dust mite, dust, and cat in the SLSJ study; and dust mite and cat in the MRC studies. àOutdoor allergens included timothy grass, olive, birch, ragweed, and pellitory in EGEA; herbs, trees, and animals in the SLSJ study; and timothy grass in the MRC studies. §Molds included Alternaria, Aspergillus, and Cladosporium species in EGEA; Alternaria, Aspergillus, Cladosporium, Hormodendrum, and Penicillium species in the SLSJ study; and Aspergillus and Cladosporium species in the MRC studies. *Total effective number of independent SNP pairs tested is estimated by the sum of the effective number of independent SNP pairs tested by gene pair over all gene pairs examined.
The multiple-testing corrected threshold is thus equal to the 5% type I error divided by the total effective number of independent SNP pairs tested (T 5 7.3 3 10
). The 2 groups contained 1354 asthmatic patients (628, 549, and 177 for EGEA and the SLSJ and MRC studies, respectively) and 1849 nonasthmatic subjects (997, 583, and 269 for EGEA and the SLSJ and MRC studies, respectively). *Gene symbol. Major allele/minor allele. àMinor allele frequency. §OR for single-SNP effect (top) or interaction between SNPs (bottom) associated with atopy assuming an additive model. kP and P int are P values associated with the Wald test of SNP effect (top) and interaction effect (bottom). {P stage2 and P stage2-int are P values associated with the Wald test of meta-analyzed single-SNP effect (top) and interaction between SNPs (bottom) in the stage 2 data sets (SLSJ and MRC studies). #P meta and P meta-int are P values associated with the Wald test of meta-analyzed single-SNP effect (top) and interaction between SNPs (bottom) in the 3data sets (EGEA and SLSJ and MRC studies). **P value associated with the Cochran Q test for homogeneity between the 2 groups of asthmatic and nonasthmatic subjects. 
